IL6 and type 2 diabetes mellitus: The anti-inflammatory actions of IL-10 may be therapeutically useful by intervention of TNF-α, IL-1 or IL-6 to avoid inflammatory response, then to decrease the CNS vulnerability, further to reduce the chance to trigger T2D.